IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crispr Therapeutics AG

CUSIP: 417182108 | 1 institutional holders

Quarters

Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2021

Fairfield, Bush & Co.7,000
0.0% of portfolio›$784
StyleTurnoverLocationFiled
Fairfield, Bush & Co.
7,000$7840.0%CoreLowDarien, CT2021-11-08